Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
11 NEW September 18, 2023
An old drug gets a new look: DNA damaging agent aclarubicin found to disrupt chromatin and stimulate RNA Pol II elongation

An old drug gets a new look: DNA damaging agent aclarubicin found to disrupt chromatin and stimulate RNA Pol II elongation

From the Henikoff Lab, Basic Sciences Division and Cancer Basic Biology Program of the Cancer Consortium
Science SpotlightJuly 17, 2023
Pinpointing pain: Is it cancer or cancer treatment?

Pinpointing pain: Is it cancer or cancer treatment?

Distinguishing side effects of treatment from a potential metastatic recurrence can be tricky; we asked cancer experts for their best advice
Hutch NewsJune 05, 2023
Second Fred Hutch clinic building opens in Seattle

Second Fred Hutch clinic building opens in Seattle

New building in South Lake Union comes with new imaging suites, automated parking and a care model that puts patients at the center of everything
Hutch NewsMarch 23, 2023
Cancer chemo side effects and how to limit them

Cancer chemo side effects and how to limit them

A Q & A with physician-scientist Dr. Gary Lyman on his new Nature review of acute chemotherapy-associated adverse events
Hutch NewsOctober 28, 2022
What’s new in breast cancer research? SABCS20 goes virtual

What’s new in breast cancer research? SABCS20 goes virtual

Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
Hutch NewsDecember 18, 2020
Cancer’s toll on the heart decades down the road

Cancer’s toll on the heart decades down the road

New research explores how to lower the risk of heart disease in childhood cancer survivors
Hutch NewsJune 01, 2020